Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.

  title={Indium-111-pentetreotide scintigraphy in Graves' ophthalmopathy.},
  author={G J Kahaly and Miguel D{\'i}az and Klaus Hahn and J{\"o}rg Beyer and Andreas Bockisch},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  volume={36 4},
UNLABELLED The radiolabeled somatostatin analog 111In-pentetreotide can sensitively demonstrate somatostatin receptor-positive localizations in diseases where activated lymphocytes play a role. Lymphocyte infiltration of retrobulbar tissue in Graves' ophthalmopathy is the rationale of receptor imaging with radionuclide-coupled 111In-pentetreotide. METHODS Forty patients with Graves' ophthalmopathy, 5 patients with orbital myositis and 10 control subjects were included in this prospective… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 16 extracted citations

Update on advanced imaging options for thyroid-associated orbitopathy.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society • 2012
View 4 Excerpts
Highly Influenced

Efficacy of (99m)Tc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves' ophthalmopathy.

American journal of nuclear medicine and molecular imaging • 2012
View 3 Excerpts

Similar Papers

Loading similar papers…